Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vitamin K tailored dosing for reversal of warfarin over-anticoagulation
2005-001007-18Phase 4Completed
- Sponsor
- Royal Victoria Infirmary
- Start
- Apr 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of phytomenadione, warfarin in warfarin-induced coagulopathy, sponsored by Royal Victoria Infirmary. Started Apr 2005; status: completed.
02
Drugs
phytomenadionewarfarin
03
Conditions
warfarin-induced coagulopathy
Beyond the preview
Go deeper on 2005-001007-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001007-18.